UK markets open in 4 hours 34 minutes

BioPharma Credit PLC (BPCR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.9720-0.0100 (-1.02%)
At close: 05:55PM BST
Full screen
Previous close0.9820
Open0.9880
Bid0.9740 x 0
Ask0.9800 x 0
Day's range0.9720 - 0.9880
52-week range0.9600 - 105.0000
Volume384,826
Avg. volume2,363,401
Market cap1.335B
Beta (5Y monthly)0.22
PE ratio (TTM)15.68
EPS (TTM)0.0620
Earnings date22 Mar 2022
Forward dividend & yield0.07 (7.16%)
Ex-dividend date05 May 2022
1y target estN/A
  • Globe Newswire

    IBA and Proton International sign contract for Proteus®ONE Proton Therapy solution in Arkansas, US

    Louvain-La-Neuve, Belgium, December 23, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces a new contract for the installation of a Proteus®ONE1 proton therapy solution with Proton International Arkansas LLC – a joint venture formed by Proton International, the University of Arkansas for Medical Sciences (UAMS), Baptist Health, and Arkansas

  • Globe Newswire

    IBA and New Mexico Cancer Center sign contract to install a Proteus®ONE proton therapy solution in Albuquerque, USA

    Louvain-La-Neuve, Belgium, December 21, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus®ONE1 proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA. The contract includes a long-term operation maintenance agreement. The contract is for the delivery of a

  • Globe Newswire

    Iba – Acquisition of Own Shares

    IBA – ACQUISITION OF OWN SHARES Immediate Release – December 20th, 2021 Louvain-la-Neuve, Belgium, December 20th, 2021 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on December 3rd, 2021. Under this program, IBA has requested a financial intermediary to repurchase up to 400.000 IBA ordinary shares on its